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The value of a
national tradition
of scientific re-
search cannot be
underestimated as
a factor favoring
productivity.recently reviewed the paper “Cardiovascular Scientific Production in Spain and in
the European and Global Context (2003–2007)” being published this month in
Revista Espanola de Cardiologia (1). As is apparent from the title, the manuscript
eported the research productivity of nations throughout the world relative to that of
pain, and was based upon a bibliometric analysis of published articles. The paper raises
he issue of the state of the worldwide cardiovascular research enterprise, an issue of
ome interest to JACC. We have always received at least 60% of our submissions from
utside of the U.S., and have seen this grow to nearly 70% in recent times. The new
rticle stimulated this essay which is being jointly published in JACC and Revista.
The data in the paper demonstrated that the United Stated ranked first as a single
ountry in the overall production of scientific cardiovascular publications, but scored sec-
nd to the aggregate European Union (EU) countries in this category. However, for
igh quality articles, that is those published in the highest quartile of journals in the
ardiac & Cardiovascular Systems category under Journal Citation Reports, the United
tates produced more than all other countries as well as the EU cohort. Japan, China
nd the English speaking countries of Australia and Canada also were also among the
eaders. Within the EU, the United Kingdom and Germany were most productive;
pain ranked sixth and ninth worldwide (tenth if only first quartile journals are consid-
red). The relative position of individual countries was altered when adjusted for popula-
ion size or gross domestic product, with Canada being particularly productive relative to
hese variables.
In assessing research productivity throughout the world, it must be acknowledged that
ibliometric methods have a number of serious limitations. Firstly, they consider only
ublished articles (as recorded in the Science Citation Index Expanded), and neglect
ther scholarly material such as patents, books, non-print venues, and training programs.
t goes without saying that analyzing only the number and not the quality of articles is a
evere failing. This particular article did not take into account cardiovascular papers pub-
ished in the general medical literature or the fact that the number of national journals
aries in individual countries. Many excellent cardiovascular manuscripts appear in the
eneral medical journals such as the New England Journal of Medicine. Finally, in assess-
ng high quality papers the article relied on the impact factor, which has obvious imper-
ections. Nevertheless, the paper in Revista does provide a gross picture of the interna-
ional state of cardiovascular research.
A number of factors are capable of influencing the research productivity of any
ountry. Most obvious and probably most important among these factors are the
conomic status, wealth and population size of the country. Wealthy nations can
rovide support for research from the government, foundations, or philanthropists.
n addition, generous reimbursement for clinical services can supply sufficient fundshis article will be simultaneously published in the December issue of Revista Española de Cardiologı´a.
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December 15/22, 2009:2460–2 Editor’s Pageo free up clinicians to perform investigation instead of
linical care. This has enabled a great deal of applied
linical research to be done in the U.S. without specific
rant support. It is apparent that a greater population
ill yield a larger pool of individuals with interest and
alent in scientific investigation, and a larger potential
arket for medical products with which to attract in-
ustrial support. It is not surprising, therefore, that the
esearch output of nations can be related well to their
ross domestic product.
The value of a national tradition of scientific re-
earch cannot be underestimated as a factor favoring
roductivity. This is well exemplified by the high re-
earch output of small nations with well developed and
upported investigative enterprises such as the Nether-
ands, Sweden, Belgium, and Switzerland. Countries
ith a long tradition of research have the appropriate
nfrastructure in place, a critical mass of investigators,
nd the mindset of the importance of new discovery.
mportantly, abundant role models will exist to attract
nd mentor the training of new investigators who are
ritical to both maintaining and expanding the research
nterprise. There can be little doubt that “research be-
ets research.” This factor has widespread implications;
t is incumbent upon the well established national re-
earch enterprises to assist developing countries in im-
lementing similar programs.
I believe that an important factor in determining the
esearch publications of any country is the role that such
roductivity plays in personal professional promotion and
dvancement. In many countries the major yardstick used
n evaluating the performance of individuals is the num-
er of publications they have authored, especially in high
mpact journals. As the cliché goes, “publish or perish”.
his stimulus to the number of publications is magnified
y the necessity to show independence, an important cri-
erion for promotion in many nations. Whether the em-
hasis upon publications as a criterion for promotion is
isplaced can be debated. However, it is clear that it can
e a major factor in producing papers in medical journals,
nd increasing the apparent research output of a country.
nfortunately, it often also leads to the splitting of data
nto multiple manuscripts and the well known minimal
ublishable unit (MPU).
As I discussed in a recent Editor’s Page (2), character-
stics of the health care systems of many countries are
dvantageous to the acquisition of research opportunities
nd support, and to the successful completion of clinical
nvestigation, especially compared to the U.S. The region-
lization of health care usually present outside of the U.S.
reatly facilitates the identification and enrollment of pa- Hients in clinical trials. A lower cost to perform experi-
ents is another definite advantage in attracting studies
or many countries, as is any reduced stringency in the
ules of Institutional Review Boards for human research.
ince the industrial sponsors of clinical investigation typi-
ally have many financial pressures, the ability to more
apidly acquire the CE mark in Europe as compared to
DA approval in the U.S. holds great appeal in placing
tudies. Of course, if the originators of new drugs/tech-
ology are located in a country, that would also favor the
erformance of clinical investigation with that invention
n that nation. All these factors contribute to the ultimate
esearch output of a nation.
Finally, several other characteristics may influence
he cardiovascular research enterprise of a nation. It is
bvious that funds, particularly from government, will
e prioritized to the most prevalent diseases. Therefore,
or countries in which infectious diseases are still the
ost common cause of death and disability, cardiovas-
ular projects will be less well supported. In addition,
or better or for worse, it is increasingly clear that En-
lish has become the language of medical science.
hose countries in which the scientific community
acks fluency in English are at a substantial disadvan-
age in having papers accepted in medical journals, es-
ecially the most competitive journals. It is likely that
hese countries may have less well developed manu-
cript presentation skills as well. Although presentation
annot salvage a flawed study, it can render a good
tudy unacceptable.
It has long been clear that biomedical research can not
nly improve a country’s health, but also serve as an en-
ine to drive economic growth and development. Accord-
ngly there has been a progressive increase in research
roductivity throughout the world. When my academic
areer began some 35 years ago, the U.S. was the unques-
ioned leader in cardiovascular investigation, and a gap
xisted between its output and that of the rest of the
orld. Over the years things have changed, and if any gap
ith other industrialized nations currently exists, it is triv-
al. Some of the increase in international research can be
ttributed to the greater support provided by industry, and
he inherent advantages of health care systems outside the
.S. for clinical investigation. The increase in research
utput, however, has not been equal for all countries, as is
vident in the paper in Revista. The heterogeneity, as is
he case for the growth of international cardiovascular
nvestigation itself, is almost certainly related to changes
n the economic state of countries in Europe and Asia.owever, the role of a tradition of research cannot be
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Editor’s Page December 15/22, 2009:2460–2nderestimated, with the infrastructure and critical mass it
rovides. In this regard, one of the most important devel-
pments has been the training of new young investigators,
hich is a requisite condition for the growth of a research
nterprise. As time goes on I believe that we can look
orward to enjoying the benefits of augmented research
rom already successful international programs and new
ontributions from emerging worldwide investigative ef-
orts. Hopefully governments will appreciate the many
alutary effects of a strong research enterprise, and support
he increasing pool of investigators and their innovative
rograms.ddress correspondence to:
r. Anthony N. DeMaria
ditor-in-Chief, Journal of the American College of Cardiology
655 Nobel Drive, Suite 630
an Diego, California 92112
-mail: ademaria@acc.org
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